Zydus Cadila gets USFDA nod for fesoterodine fumarate extend

Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...

✕

Zydus Cadila gets USFDA nod for fesoterodine fumarate extended release capsules in strengths of 4 mg and 8 mg

Oct 6, 20172016 views

Zydus Cadila has received final approval from the USFDA to market fesoterodine fumarate extended-release capsules in strengths of 4 mg and 8 mg. The drug is used in treating overactive bladder with symptoms such as urinary frequency...

http://www.thehindubusinessline.com/companies/zydus-cadila-gets-usfda-nod-for-overactive-bladder-drug/article9888491.ece

Preview

Zydus Cadila gets USFDA nod for fesoterodine fumarate extended release capsules in strengths of 4 mg and 8 mg

Zydus Cadila gets USFDA nod for fesoterodine fumarate extended release capsules in strengths of 4 mg and 8 mg

www.thehindubusinessline.com

Like

Comment

Share